Unleashing the Power of LLMs: Revolutionizing Drug Safety and Business Automation with Multi-Agent AI

This 31-minute conference talk from All Things Open AI 2025 features Jeffery Painter from GSK and Venkateswara Rao Chalamalasetti from Tech Mahindra exploring how Large Language Models (LLMs) are transforming pharmaceutical safety and business processes. Discover case studies demonstrating AI's advancement of drug safety science, including enhanced chatbot interactions and natural language query conversion to database searches. Learn about guidelines developed for regulated environments to prevent hallucinations in translation tasks, ensuring trustworthy AI implementation. Explore the potential of LLM-based multi-agent systems in business process automation, examining how agents equipped with planning, memory, and tool modules can autonomously perform complex tasks. Address challenges in multi-agent communication, coordination, and integration with external systems. Gain practical insights into LLM applications, understand regulatory considerations for trustworthy AI, and see how multi-agent systems enhance efficiency and scalability across various applications.